Xencor Inc (NASDAQ:XNCR) shares are trading higher after it was announced the company will replace HFF Inc (NYSE:HF) in the S&P SmallCap 600 on July 2.
Xencor is a pharmaceutical manufacturer with an emphasis on addressing severe diseases.
HFF provides capital markets and brokerage services to owners of commercial real estate. In March, Jones Lang LaSalle Inc. (NYSE:JLL) announced it's acquiring HFF in a cash and stock transaction with an equity value of approximately $2 billion.
Xencor shares traded higher by 13% to $38.42 at time of publication Tuesday. The stock has a 52-week range between $48.38 and $27.75.
Related Links:
Genfit Partners With Terns Pharma To Develop, Commercialize Elafibranor In China
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
